Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Furman

Showing results (181-190 of 199) with videos related to

Pageof 20
Sort By:
Bioorganic & Medicinal Chemistry Letters|June 29, 2010
Synthesis and anti-HCV activity of 3',4'-oxetane nucleosidesWonsuk Chang, Jinfa Du, Suguna Rachakonda, et al.
Journal of Medicinal Chemistry|January 31, 2014
Discovery of a novel class of potent HCV NS4B inhibitors: SAR studies on piperazinone derivativesRamesh Kakarla, Jian Liu, Devan Naduthambi, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 14, 2015
Investigation of the binding and functional properties of extended length D3 dopamine receptor-selective antagonistsCheryse A Furman, Rebecca A Roof, Amy E Moritz, et al.
Antimicrobial Agents and Chemotherapy|December 20, 2000
Mechanism of action of 1-beta-D-2,6-diaminopurine dioxolane, a prodrug of the human immunodeficiency virus type 1 inhibitor 1-beta-D-dioxolane guanosineP A Furman, J Jeffrey, L L Kiefer, et al.
Digestive Diseases and Sciences|September 5, 2018
A New Look at Familial Risk of Inflammatory Bowel Disease in the Ashkenazi Jewish PopulationElena R Schiff, Matthew Frampton, Francesca Semplici, et al.
Journal of Medicinal Chemistry|August 19, 2005
Design, synthesis, and antiviral activity of 2'-deoxy-2'-fluoro-2'-C-methylcytidine, a potent inhibitor of hepatitis C virus replicationJeremy L Clark, Laurent Hollecker, J Christian Mason, et al.
Antiviral Chemistry & Chemotherapy|October 18, 2006
Inhibition of hepatitis C replicon RNA synthesis by beta-D-2'-deoxy-2'-fluoro-2'-C-methylcytidine: a specific inhibitor of hepatitis C virus replicationLieven J Stuyver, Tamara R McBrayer, Phillip M Tharnish, et al.
Antiviral Research|May 24, 2011
Activity and the metabolic activation pathway of the potent and selective hepatitis C virus pronucleotide inhibitor PSI-353661Phillip A Furman, Eisuke Murakami, Congrong Niu, et al.
Clinical Spine Surgery|March 27, 2024
A Mechanistic and Preclinical Assessment of BioRestore Bioactive Glass as a Synthetic Bone Graft Extender and Substitute for Osteoinduction and Spine FusionElianna J Fred, Silvia Minardi, Alyssa M Goodwin, et al.
Bioorganic & Medicinal Chemistry Letters|August 16, 2012
β-D-2'-α-F-2'-β-C-Methyl-6-O-substituted 3',5'-cyclic phosphate nucleotide prodrugs as inhibitors of hepatitis C virus replication: a structure-activity relationship studyJinfa Du, Donghui Bao, Byoung-Kwon Chun, et al.
Pageof 20

Showing results (181-190 of 199) with videos related to

Sort By:
Pageof 20
Bioorganic & Medicinal Chemistry Letters|June 29, 2010
Synthesis and anti-HCV activity of 3',4'-oxetane nucleosidesWonsuk Chang, Jinfa Du, Suguna Rachakonda, et al.
Journal of Medicinal Chemistry|January 31, 2014
Discovery of a novel class of potent HCV NS4B inhibitors: SAR studies on piperazinone derivativesRamesh Kakarla, Jian Liu, Devan Naduthambi, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 14, 2015
Investigation of the binding and functional properties of extended length D3 dopamine receptor-selective antagonistsCheryse A Furman, Rebecca A Roof, Amy E Moritz, et al.
Antimicrobial Agents and Chemotherapy|December 20, 2000
Mechanism of action of 1-beta-D-2,6-diaminopurine dioxolane, a prodrug of the human immunodeficiency virus type 1 inhibitor 1-beta-D-dioxolane guanosineP A Furman, J Jeffrey, L L Kiefer, et al.
Digestive Diseases and Sciences|September 5, 2018
A New Look at Familial Risk of Inflammatory Bowel Disease in the Ashkenazi Jewish PopulationElena R Schiff, Matthew Frampton, Francesca Semplici, et al.
Journal of Medicinal Chemistry|August 19, 2005
Design, synthesis, and antiviral activity of 2'-deoxy-2'-fluoro-2'-C-methylcytidine, a potent inhibitor of hepatitis C virus replicationJeremy L Clark, Laurent Hollecker, J Christian Mason, et al.
Antiviral Chemistry & Chemotherapy|October 18, 2006
Inhibition of hepatitis C replicon RNA synthesis by beta-D-2'-deoxy-2'-fluoro-2'-C-methylcytidine: a specific inhibitor of hepatitis C virus replicationLieven J Stuyver, Tamara R McBrayer, Phillip M Tharnish, et al.
Antiviral Research|May 24, 2011
Activity and the metabolic activation pathway of the potent and selective hepatitis C virus pronucleotide inhibitor PSI-353661Phillip A Furman, Eisuke Murakami, Congrong Niu, et al.
Clinical Spine Surgery|March 27, 2024
A Mechanistic and Preclinical Assessment of BioRestore Bioactive Glass as a Synthetic Bone Graft Extender and Substitute for Osteoinduction and Spine FusionElianna J Fred, Silvia Minardi, Alyssa M Goodwin, et al.
Bioorganic & Medicinal Chemistry Letters|August 16, 2012
β-D-2'-α-F-2'-β-C-Methyl-6-O-substituted 3',5'-cyclic phosphate nucleotide prodrugs as inhibitors of hepatitis C virus replication: a structure-activity relationship studyJinfa Du, Donghui Bao, Byoung-Kwon Chun, et al.
Pageof 20